Research Exploring Sleep Education & Technology
RESET
1 other identifier
interventional
1,060
1 country
1
Brief Summary
A pilot study that seeks to develop a set of typologies of users of mobile sleep tracking technologies, and optimal sleep health educational strategies among users of mobile wearable technologies that track sleep.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2018
CompletedFirst Posted
Study publicly available on registry
April 5, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedJanuary 30, 2020
January 1, 2020
6 months
March 26, 2018
January 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Sleep time measured by wearable mobile sleep tracking technology
Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients
15 Days
Time in deep sleep measured by wearable mobile sleep tracking technology
Mobile sleep tracking device will be worn by patient for 15 days and will measure sleep patterns in patients
15 Days
Dysfunctional Beliefs about Sleep (DBAS) scale
24-item DBAS scale with five subscales corresponding to: (1) consequences of insomnia (2) control and predictability of sleep (3) sleep requirement expectations (5) sleep-promoting practices
1 Day
Measure of motivation to change using the Change Assessment Scale (CAS)
8 scale measure divided into 4 separate scales: Scale 1: "Pre-Contemplation" Scale 2: "Contemplation" Scale 3 "Action" Scale 4 "Maintenance"
15 Days
Study Arms (2)
Receive sleep health messages + GAD
ACTIVE COMPARATORProcedures will be delivered to users of the GAD, individuals who have opted in via their smartphone application, to receive messages about various areas of health.
Sleep message No GAD
ACTIVE COMPARATORFor two weeks participants agree to receive sleep health messages and wear the GAD
Interventions
Over the course of 2 weeks' participants will receive specialized sleep-related message interventions to encourage sleep awareness via the smartphone application.
Survey responses will be merged with objective GAD data (sleep time, time in deep sleep, physical activity) which will assist in developing message design formats for message testing.
Eligibility Criteria
You may qualify if:
- A current user of the OURA ring activity and sleep tracker device.
- Health conscious.
You may not qualify if:
- Non English speakers.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York University School of Medicine
New York, New York, 10016, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Girardin Jean-Louis, MD
NYU Langone Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2018
First Posted
April 5, 2018
Study Start
February 1, 2019
Primary Completion
August 1, 2019
Study Completion
August 1, 2019
Last Updated
January 30, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Immediately following publication. No end date
- Access Criteria
- Requests should be directed to Rebecca.robbins@nyulangone.org. To gain access, data requestors will need to sign a data access agreement
All of the individual participant data collected during the trial, after deidentification.